8 reports

Crisis intervention services typically include advice and information for individuals with HIV/ AIDS or with issues related to substance abuse, pregnancy, parenting, health matters, contraception and sexually transmitted diseases.

  • Addictions
  • Healthcare
  • United States
  • Forecast

Sharing needles when injecting a substance of abuse greatly increases the risk of HIV/ AIDS, hepatitis, tuberculosis, and other blood-borne diseases such as infections.

  • Addictions
  • World
  • Actavis plc
  • Allergan plc
  • Pfizer Inc.
  • Clinical Trial profile. 205 Trial Title
  • Official Title
  • Addictions
  • Clinical Trial
  • Pharmaceutical
  • United States
  • World
  • Clinical Trial profile. 414 Trial Title
  • Prominent Drugs

HIV Infected Women: Randomized Trial Clinical Trial to Reduce Drinking in Women with HIV (WHATIF) GDCT## NCT##, U## AA##-## Central Nervous System Alcohol Addiction, Human Immunodeficiency Virus (HIV) Infections (AIDS) (T Cell Surface Glycoprotein C

  • Addictions
  • Neurology
  • United States
  • World
  • Alkermes plc
  • Clinical Trial profile. 206 Trial Title
  • Clinical Trial profile. 213 Trial Title

HIV-comorbidities With Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected Russians Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV) (St PETER HIV) GDCT## NCT##, U##AA##; ##U##AA##

  • Addictions
  • Neurology
  • United States
  • World
  • Alkermes plc

Eligible participants are randomized, stratified by HIV serostatus, to ibudilast ## mg twice a day or placebo treatment for ## weeks, with twice weekly clinic visits for counseling, urine drug tests, and safety/ medication adherence monitoring.

  • Addictions
  • Opioid
  • Therapy
  • United States
  • Product Initiative

Eligible participants are randomized, stratified by HIV serostatus, to ibudilast ## mg twice a day or placebo treatment for ## weeks, with twice weekly clinic visits for counseling, urine drug tests, and safety/ medication adherence monitoring.

  • Addictions
  • Opioid
  • Therapy
  • United States
  • Product Initiative

Aphios Corporation is developing APH-## (nanoformulation of tetrahydrocannabinol, delta ##-THC) for the treatment of marijuana addiction, pain in cancer and AIDS patients, cachexia in cancer and HIV/ AIDS patients as well as multiple sclerosis, chemotherapy induced na

  • Addictions
  • Research And Development
  • United States
  • Company
  • Product Initiative